tirzepatide or semaglutide for pcos Rising use of GLP-1 medications among women with Tirzepatide for PCOS: Metabolic Benefits

In pregnant rats administered semaglutide at the human clinical dose for two weeks prior to mating and during pregnancy, there was increased fetal death and structural abnormalities

Current head-to-head evidence suggests tirzepatide may produce greater average weight loss than semaglutide

This is when moderate, informed drinking is most feasible

Patients should rotate injection sites (abdomen, thigh, or upper arm), allow the medication to reach room temperature before injection, and ensure proper technique

Additional factors that influence skin elasticity during weight loss: rate of weight loss (slower is better for skin adaptation), hydration, age, genetics, and nutritional status